Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum lipids in Norplant implants users: a cross-sectional study.

B Affandi1, S K Suherman, Djajalelana

  • 1Department of Obstetrics and Gynaecology, School of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta.

Contraception
|October 1, 1987
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to "An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon" [Contraception 58 (1998) S99-S107].

Contraception·2025
Same author

Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?

Human reproduction (Oxford, England)·2002
Same author

Endometrial expression of glycodelin in women with levonorgestrel-releasing subdermal implants.

Fertility and sterility·2001
Same author

Expression of the chemokines, monocyte chemotactic protein (MCP)-1 and MCP-2 in endometrium of normal women and Norplant users, does not support a central role in macrophage infiltration into endometrium.

Journal of reproductive immunology·2001
Same author

Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception.

Molecular human reproduction·2000
Same author

Oxidative stress, vitamin E and progestin breakthrough bleeding.

Human reproduction (Oxford, England)·2000

Norplant implants did not significantly alter triglycerides or HDL-cholesterol levels. However, total cholesterol and LDL-cholesterol showed significant changes with Norplant use, indicating a potential metabolic effect of this hormonal contraceptive.

Area of Science:

  • Endocrinology
  • Metabolic studies
  • Reproductive health

Background:

  • Hormonal contraceptives require safety and risk assessment through metabolic effect studies.
  • Norplant implants are a progestin-only contraceptive method with potential systemic effects.

Purpose of the Study:

  • To evaluate the impact of Norplant implants on serum lipid profiles.
  • To assess metabolic changes associated with different durations of Norplant use.

Main Methods:

  • A cross-sectional study involving 8 groups based on Norplant usage duration (pre-insertion to post-removal).
  • Serum lipid parameters including triglycerides, total cholesterol, HDL-cholesterol, and LDL-cholesterol were analyzed.
  • Blood samples were collected after an overnight fast.
Keywords:
AsiaBiologyContraceptionContraceptive AgentsContraceptive Agents, FemaleContraceptive ImplantsContraceptive MethodsCross Sectional AnalysisData AnalysisDemographic AnalysisDemographic FactorsDeveloping CountriesFamily PlanningIndonesiaLipid Metabolic Effects--changesLipidsMetabolic EffectsPhysiologyPopulationPopulation CharacteristicsResearch MethodologySoutheastern Asia

Related Experiment Videos

Main Results:

  • No statistically significant differences were observed in triglyceride and HDL-cholesterol levels across the groups (p > 0.05).
  • Significant differences were found in total cholesterol and LDL-cholesterol levels among the groups (p < 0.01).

Conclusions:

  • Norplant use is associated with significant alterations in total cholesterol and LDL-cholesterol.
  • While triglycerides and HDL-cholesterol remained stable, changes in total and LDL cholesterol warrant consideration in the risk-benefit profile of Norplant.